Aniruddha Sahasrabuddhe

Ani is currently working at Amgen Thousand Oaks as a Principal Scientist in the large molecule discovery research. Ani also worked in the small molecule discovery research at Amgen Thousand Oaks, where he was responsible for establishing high throughput mass spectrometry platforms for early drug discovery. Ani has an extensive experience in analytical instrumentation, technology evaluation, technology transfer, building high throughput screening and analytical characterization platforms for drug discovery, biologics’ early molecular assessment, and deeper molecular characterization. Ani has completed his doctoral research from the Ohio State University under the supervision of Dr. Vicki Wysocki where his work has been published in the high impact journals such as Nature, Science, PNAS, etc.